NCT05864885Phase 1Status unknown
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
Phase I Study of Safety and Pharmacokinetics of Once-Daily Topical Solution in Male Subjects With Androgenetic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Phase 1
- Sponsor
- Aneira Pharma, Inc.
- Participants (registry)
- 14
- Start
- June 2023
- Primary completion
- July 2023
- Study completion
- July 2023
- Last registry update
- May 2023
- Countries
- —
Conditions studied: Androgenetic Alopecia
Interventions: Minoxidil, Latanoprost
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.